Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-161-6 | CAS number: 766-09-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
There was only one study available, which showed dealkylation of 1-ethylpiperidine to piperidine, which is N-oxidized to the corresponding N-Hydroxyamine. Based on the low molecular weight, moderate water solubility, and moderate octanol-water partition coefficient absorption after oral administration can be expected. The test item has moderate vapour pressure and volatility and due to moderate water solubility may be retained within the mucus after inhalation followed by local irritation and may pass across the respiratory epithelium. The moderate log P value may favour absorption directly across the respiratory tract epithelium by passive diffusion. However, due to the corrosive potential of the test item mainly local effects have to be expected. Concerning the dermal route, rather local effects leading to destruction of membrane barriers than systemic effects have to be considered. Due to molecular weight and water solubility, excretion is likely to be expected by the kidney.
Key value for chemical safety assessment
Additional information
Assessment of the Toxicokinetic Behaviour
1-Ethylpiperidine (molecular weight of 113.2 g/mol) is a colourless to yellowish liquid with an amine-like odor, pH value of 12.2 at a concentration of 50 g/L and 20 °C, water solubility of 6 g/L at 20 °C (GESTIS 2011, see chapter “water solubility”) and a vapour pressure of 12.76 hPa at 20 °C (BASF 1987, see chapter “vapour pressure”). The log P for the molecule was determined to be 1.49 at 25 °C at a pH of 10.2 to 10.5 (BASF 1988, see chapter “partition coefficient”), indicating no accumulation of the substance.
There was one study available on the cleavage of 1-Ethylpiperidine by the 9000 x g supernatant of mouse and rat liver in vitro (Kimura 1979, Val 4). No other studies were available in which the toxicokinetic properties of 1-Ethylpiperidine were investigated.
Absorption
Data on absorption can only be taken from acute (oral, inhalative and dermal) studies.
In an acute oral toxicity study, rats were administered the substance by gavage at doses of 165 to 1322 mg/kg bw., a LD50 of ca. 280 mg/kg bw was determined, clinical signs such as sedate behaviour; spasmodic convulsions; opisthotonus; flexor spasms; tremor; dyspnea; lacrimation; salivation; exophthalmus; chromodakryorrhoe; crouching position; accelerated, irregular respiration; scrubby fur. No abnormalities were noted at necropsy of deceased and sacrificed animals (BASF, XX/36, 1970, see chapter “acute oral toxicity”). Due to the low molecular weight may pass through aqueous pores or be carried through the epithelial barrier by the bulk passage of water. Additionally, the moderate log P may facilitate absorption of the test compound in the gastrointestinal tract by passive diffusion (ECHA Guidance 7c, 2008).
The test compound has a moderate vapour pressure and volatility. In an inhalation hazard exposure for 10 min to an atmosphere that had been saturated at 20 degrees centigrade with the volatile parts of the compound all animals died within 10 min (BASF, XX/36, 1970, see chapter “acute inhalative toxicity”). Clinical signs included gasping, strong mucosal irritation, agony, tremor, convulsions and disturbances of equilibrium. These effects at the site of action and mortality are caused primarily by the strong corrosive mode of action of the substance.
In an acute inhalative toxicity study, rats were whole body exposed at concentrations of 1.88 to 6.84 mg/L, a LC50 (male and female rat, 4h) of 2.42 mg/L was determined. Clinical signs were restless behavior, gasping respiration, lid closure, anemic aspect, tremors and convulsions (saltatory spasms), sighing, jerky and irregular respiration, salivation, lateral or abdominal position, reddish discharge from the noses, encrustations and ruffled fur after inhalation of an aerosol for 4 hours (BASF85/207, 1987, see chapter “acute inhalative toxicity”). Due to the moderate water solubility, the test substance may be retained within the mucus after inhalation followed by local irritation and may pass across the respiratory epithelium. Thereby, the moderate log P value may favour absorption directly across the respiratory tract epithelium by passive diffusion. However, due to the corrosive potential of the test substance the main effects are local effects.
In an acute dermal study the LD50 for male and female rabbits was > 200 mg/kg bw. Clinical signs were irritation and formation of necrosis, no systemic effects were observed (BASF 77/515, 1980, see chapter “acute dermal toxicity”). Therefore, the primary action of the test item is the local effect which led to destruction of membrane barriers.
Metabolism
In rat and mouse liver in vitro N-C-cleavage was investigated and dealkylation of N-Ethylpiperidine to piperidine was shown (Kimura et al., 1979, Yakugaku Zasshi 99, 228-234 and Kimura et al., 1979, Yakugaku Zasshi 99, 235-239). Piperidine is N-oxidized to the corresponding N-Hydroxylamine. Other metabolites are 2,3,4,5-tetrahydropyridine-1-oxide, 3-hydroxy piperidine, 4-hydroxy piperidine and Piperidone-2 (Wang et al., 1989, Acta Pharmacol. Sin. 10, 252-256 and Okano et al., 1978, Japan. J. Pharmacol. 28: 41-47).
Studies on genotoxicity, in mammalian cells gave indications of a reactivity of the substance or its metabolites under the test conditions as shown by cytotoxicity in treatments with or without metabolic activation. No increased Mutagenicity was observed.
Excretion
1-Ethylpiperidine has a molecular weight of 113.2 g/mol and has moderate water solubility and is therefore likely to be excreted predominantly via the urine (ECHA GD 7c, 2008). The metabolite piperidine is excreted by the kidneys, too. Okano et al., 1978 (J. Pharmacol. 28: 41-47) found unchanged piperidine, 3-hydroxypiperidine, 4-hydroxypiperidine, and two unidentified metabolites in urine collected over 72 hours after i.p. injection of rats with [³H]piperidine.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.